Generics

Branded cardiovascular drugs not better than generics

Generics/Research | Posted 29/07/2009

In December 2008, the Journal of the American Medical Association published an article on the clinical equivalence of generic and brand-name drugs used in cardiovascular disease by Aaron Kesselheim, et al. of Harvard Medical School, Boston, MA, USA.

Pressures on generic medicines put EU healthcare at risk

Generics/General | Posted 06/07/2009

“The future of the European generic medicines industry is under serious threat, which places both the sustainability of European health care and the European industrial competitiveness at serious risk,” warned Mr Greg Perry, Director General of the European Generics medicines Association (EGA), at an EGA conference on healthcare sustainability on 31 March 2009 in Prague, Czech Republic.

Nomura: Generics growth will be steady for EU but anaemic for US

Generics/News | Posted 06/07/2009

Between now and 2012, growth in the European generics market is expected to expand at less than 10% a year according to Ms Frances Cloud, co-head of healthcare investment banking at Nomura International, as she told the World Generics Medicines Congress Europe 2009, held in London, UK, in February.